{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:04:39Z","timestamp":1791291879840,"version":"4.1.0"},"reference-count":43,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,7,30]],"date-time":"2010-07-30T00:00:00Z","timestamp":1280448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[2011,3]]},"abstract":"<jats:sec><jats:label\/><jats:p><jats:italic>J. Neurochem.<\/jats:italic> (2011) <jats:bold>116<\/jats:bold>, 721\u2013725.<\/jats:p><\/jats:sec><jats:sec><jats:title>Abstract<\/jats:title><jats:p>The conformational conversion of the cellular prion protein (PrP<jats:sup>C<\/jats:sup>) to the infectious form (PrP<jats:sup>Sc<\/jats:sup>) is the critical step in the pathogenesis of prion diseases such as Creutzfeldt\u2010Jakob disease in humans and scrapie in sheep. Cholesterol\u2010rich lipid rafts play a key role in the conversion of PrP<jats:sup>C<\/jats:sup> to PrP<jats:sup>Sc<\/jats:sup> and other cellular components have been identified as important cofactors to trigger, enhance, or accelerate prion formation. Amongst these heparan sulphate proteoglycans (HSPGs) and their glycosaminoglycan side\u2010chains have been implicated in prion metabolism. Recently, the cell\u2010surface HSPG glypican\u20101 was demonstrated to co\u2010localise with PrP<jats:sup>C<\/jats:sup> on the cell surface and to promote its association with lipid rafts. Both PrP<jats:sup>C<\/jats:sup> and PrP<jats:sup>Sc<\/jats:sup> co\u2010immunoprecipitated with glypican\u20101 and the interaction was dependent on the glycosaminoglycan side chains of glypican\u20101. Critically, depletion of glypican\u20101 in scrapie\u2010infected N2a cells reduced the formation of PrP<jats:sup>Sc<\/jats:sup>, indicating that this HSPG is involved in prion formation. Further work is required to understand the molecular and cellular mechanisms underpinning the role of glypican\u20101 and possibly other members of the glypican family in prion metabolism, and to determine whether glypican\u20101 facilitates PrP<jats:sup>Sc<\/jats:sup> formation <jats:italic>in vivo<\/jats:italic>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1471-4159.2010.06936.x","type":"journal-article","created":{"date-parts":[[2010,8,20]],"date-time":"2010-08-20T04:53:18Z","timestamp":1282279998000},"page":"721-725","source":"Crossref","is-referenced-by-count":24,"title":["Glypican\u20101 facilitates prion conversion in lipid rafts"],"prefix":"10.1111","volume":"116","author":[{"given":"Nigel M.","family":"Hooper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,2,9]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.19073-0"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2006.03909.x"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.31.060407.125620"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/21.5.1031"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M313061200"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.12.5432-5440.2000"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2004.12.002"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature05294"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.67.2.643-650.1993"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.32.19173"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M503973200"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-9781(02)00068-2"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1385\/JMN:29:3:195"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-5-224"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21420"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1529\/biophysj.107.114108"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1534-5807(02)00180-6"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1681"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M411314200"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/096876899294607"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M500122200"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.3.409"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2004.08.005"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15486-X"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M203248200"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.10.6324"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj20020773"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0609621104"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16811-6"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.20025"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2003.10.150"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.50.30221"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00687367"},{"key":"e_1_2_11_35_1","first-page":"601","article-title":"Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann\u2010Straussler syndrome, Creutzfeldt\u2010Jakob disease and scrapie","volume":"63","author":"Snow A. D.","year":"1990","journal-title":"Lab. Invest."},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.129.1.121"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/09687860500449994"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000666"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20070511"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.25.14945"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2008.10.012"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110406200"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.3.377"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69835-8"}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-4159.2010.06936.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-4159.2010.06936.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T09:10:24Z","timestamp":1694509824000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-4159.2010.06936.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,9]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["10.1111\/j.1471-4159.2010.06936.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06936.x","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"value":"0022-3042","type":"print"},{"value":"1471-4159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,9]]}}}